上海医药：溴吡斯的明口服溶液获得批准生产

每日经济新闻01-09

每经AI快讯，1月9日，上海医药(601607.SH)公告称，公司下属上海上药中西制药有限公司的溴吡斯的明口服溶液收到国家药品监督管理局颁发的《药品注册证书》，该药品获得批准生产。溴吡斯的明口服溶液用于治疗重症肌无力，最早由BAUSCH公司研发，于1965年在美国上市。2024年4月，上药中西就该药品向国家药监局提出注册上市申请，并获受理。截至公告日，公司针对该药品已投入的研发费用约人民币...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2602325106?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-09 16:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602325106","market":"hk","top_or_hot":-1,"title":"上海医药：溴吡斯的明口服溶液获得批准生产","media":"每日经济新闻","content":"<div>\n<p>每经AI快讯，1月9日，上海医药(601607.SH)公告称，公司下属上海上药中西制药有限公司的溴吡斯的明口服溶液收到国家药品监督管理局颁发的《药品注册证书》，该药品获得批准生产。溴吡斯的明口服溶液用于治疗重症肌无力，最早由BAUSCH公司研发，于1965年在美国上市。2024年4月，上药中西就该药品向国家药监局提出注册上市申请，并获受理。截至公告日，公司针对该药品已投入的研发费用约人民币...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202601093614241842.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>上海医药：溴吡斯的明口服溶液获得批准生产</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n上海医药：溴吡斯的明口服溶液获得批准生产\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-09 16:38 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202601093614241842.html><strong>每日经济新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>每经AI快讯，1月9日，上海医药(601607.SH)公告称，公司下属上海上药中西制药有限公司的溴吡斯的明口服溶液收到国家药品监督管理局颁发的《药品注册证书》，该药品获得批准生产。溴吡斯的明口服溶液用于治疗重症肌无力，最早由BAUSCH公司研发，于1965年在美国上市。2024年4月，上药中西就该药品向国家药监局提出注册上市申请，并获受理。截至公告日，公司针对该药品已投入的研发费用约人民币...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202601093614241842.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0175","symbol_name":"白马股","start_time":0,"source_url":"http://finance.eastmoney.com/a/202601093614241842.html","article_id":"2602325106","we_media_id":null,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601093614241842.html","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2602325106","pubTimestamp":1767947913,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"每经AI快讯，1月9日，上海医药(601607.SH)公告称，公司下属上海上药中西制药有限公司的溴吡斯的明口服溶液收到国家药品监督管理局颁发的《药品注册证书》，该药品获得批准生产。溴吡斯的明口服溶液用于治疗重症肌无力，最早由BAUSCH公司研发，于1965年在美国上市。2024年4月，上药中西就该药品向国家药监局提出注册上市申请，并获受理。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"601607":"上海医药","BK0175":"白马股","BK0196":"行业龙头","BK0187":"一线龙头","BK0184":"上海国资改革","BK0099":"上海本地重组","BK0209":"零售","BK0097":"医药电商","BK0028":"国家队","BK0020":"浦东新区","BK1197":"保健护理产品经销商","BK0183":"MSCI概念","02607":"上海医药","BK0188":"融资融券","BK0012":"证金概念"},"translate_title":"Shanghai Pharmaceuticals: Pyridostigmine Bromide Oral Solution Approved for Production","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601607":1.5,"02607":1.5},"content_text":"每经AI快讯，1月9日，上海医药(601607.SH)公告称，公司下属上海上药中西制药有限公司的溴吡斯的明口服溶液收到国家药品监督管理局颁发的《药品注册证书》，该药品获得批准生产。溴吡斯的明口服溶液用于治疗重症肌无力，最早由BAUSCH公司研发，于1965年在美国上市。2024年4月，上药中西就该药品向国家药监局提出注册上市申请，并获受理。截至公告日，公司针对该药品已投入的研发费用约人民币231.74万元。该药品获得批准生产，有利于扩大市场份额，提升市场竞争力，并为公司后续产品开展仿制药申报积累经验。但该药品可能存在销售不达预期等情况，具有较大不确定性。（文章来源：每日经济新闻）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2602325106","isCrawlerRequest":true}